Jazz Pharmaceuticals plc — Form 8-K
Filed August 31, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Jazz Investments I Limited (Bermuda) issued $1,250,000,000 principal amount of 1.875% Exchangeable Senior Notes due September 15, 2032, guaranteed by Jazz Pharmaceuticals plc (Ireland). Initial exchange rate: 2.8150 ordinary shares per $1,000 principal. Notes exchangeable into cash and ordinary shares under specified conditions; redeemable by issuer after Sept 20, 2029 if stock trades 130%+ of exchange price. Trustee: U.S. Bank Trust Company.
Why this rating
Large financing ($1.25B = ~20% of $6.3B market cap) but routine exchangeable debt issuance. Standard terms, no change to business operations or governance disclosed.
See more from August 31, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.